These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26458049)

  • 21. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes.
    Wu LS; Hsieh CH; Pei D; Hung YJ; Kuo SW; Lin E
    Nephrol Dial Transplant; 2009 Nov; 24(11):3360-6. PubMed ID: 19506043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of type 2 diabetes.
    Ahlqvist E; Ahluwalia TS; Groop L
    Clin Chem; 2011 Feb; 57(2):241-54. PubMed ID: 21119033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal models of GWAS-identified type 2 diabetes genes.
    da Silva Xavier G; Bellomo EA; McGinty JA; French PM; Rutter GA
    J Diabetes Res; 2013; 2013():906590. PubMed ID: 23710470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
    Florez JC
    Diabetologia; 2017 May; 60(5):800-807. PubMed ID: 28283684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From genetic association to molecular mechanism.
    van de Bunt M; Gloyn AL
    Curr Diab Rep; 2010 Dec; 10(6):452-66. PubMed ID: 20878272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mining the Genome for Therapeutic Targets.
    Florez JC
    Diabetes; 2017 Jul; 66(7):1770-1778. PubMed ID: 28603140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes.
    Jung S
    Exp Mol Med; 2018 Apr; 50(4):1-13. PubMed ID: 29674722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One small step for mice, one giant leap for GWAS?
    Herman MA; Campbell JE; D'Alessio DA
    J Clin Invest; 2019 Oct; 129(10):4083-4085. PubMed ID: 31498152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical translation of genetic predictors for type 2 diabetes.
    Majithia AR; Florez JC
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):100-6. PubMed ID: 19306524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genes, Genetics, and Environment in Type 2 Diabetes: Implication in Personalized Medicine.
    Kaul N; Ali S
    DNA Cell Biol; 2016 Jan; 35(1):1-12. PubMed ID: 26495765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human genetics as a model for target validation: finding new therapies for diabetes.
    Thomsen SK; Gloyn AL
    Diabetologia; 2017 Jun; 60(6):960-970. PubMed ID: 28447115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug repositioning for diabetes based on 'omics' data mining.
    Zhang M; Luo H; Xi Z; Rogaeva E
    PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-omics characterization of type 2 diabetes associated genetic variation.
    Mandla R; Lorenz K; Yin X; Bocher O; Huerta-Chagoya A; Arruda AL; Piron A; Horn S; Suzuki K; Hatzikotoulas K; Southam L; Taylor H; Yang K; Hrovatin K; Tong Y; Lytrivi M; Rayner NW; Meigs JB; McCarthy MI; Mahajan A; Udler MS; Spracklen CN; Boehnke M; Vujkovic M; Rotter JI; Eizirik DL; Cnop M; Lickert H; Morris AP; Zeggini E; Voight BF; Mercader JM
    medRxiv; 2024 Jul; ():. PubMed ID: 39072045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-Throughput Approaches onto Uncover (Epi)Genomic Architecture of Type 2 Diabetes.
    Dziewulska A; Dobosz AM; Dobrzyn A
    Genes (Basel); 2018 Jul; 9(8):. PubMed ID: 30050001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-environment interactions in the development of type 2 diabetes: recent progress and continuing challenges.
    Cornelis MC; Hu FB
    Annu Rev Nutr; 2012 Aug; 32():245-59. PubMed ID: 22540253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Network medicine and type 2 diabetes mellitus: insights into disease mechanism and guide to precision medicine.
    Loscalzo J
    Endocrine; 2019 Dec; 66(3):456-459. PubMed ID: 31410748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression signature: a powerful approach for drug discovery in diabetes.
    Sithara S; Crowley TM; Walder K; Aston-Mourney K
    J Endocrinol; 2017 Feb; 232(2):R131-R139. PubMed ID: 27927696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies.
    Basile KJ; Johnson ME; Xia Q; Grant SF
    Int J Endocrinol; 2014; 2014():769671. PubMed ID: 24719615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "H" for Heterogeneity in the Algorithm for Type 2 Diabetes Management.
    Silvia P; Simona Z; Ernesto M; Raffaella B
    Curr Diab Rep; 2020 Mar; 20(5):14. PubMed ID: 32198647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the Verge of Precision Medicine in Diabetes.
    Li JH; Florez JC
    Drugs; 2022 Sep; 82(13):1389-1401. PubMed ID: 36123514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.